关键信息
-
基因名
IER2
- 应用
-
别名
ETR101; Immediate early response gene 2 protein
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BTL4
-
表达区间
Met1~Phe223
-
分子量
26kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
IER2 (Immediate Early Response 2) is a gene that encodes a protein implicated in various cellular processes, including stress response, growth regulation, and apoptosis. Research into IER2 recombinant proteins gained momentum due to the protein's potential role in cancer biology and neurodegenerative diseases. Its expression is often upregulated in response to extracellular stimuli, suggesting a regulatory function in cellular signaling pathways. The study of IER2 proteins, especially their recombinant forms, enables researchers to investigate their structural and functional properties in vitro, as well as their interactions with other cellular molecules. Understanding IER2's mechanism of action could reveal insights into tumor progression and resistance to therapies, making it a target of interest in drug discovery. Moreover, recombinant IER2 proteins can be utilized in the development of antibodies and the study of post-translational modifications, further expanding their applicability in both basic and applied biomedical research.
